INTRODUCTION {#S1}
============

DNA associates with histone proteins (H2A, H2B, H3, and H4) to form nucleosomes, the fundamental repeating unit of chromatin. Access to DNA for processes such as DNA replication, transcription, and repair depend on histone chaperones and ATP-dependent chromatin remodelers to dismantle and reassemble chromatin structure ([@R23]; [@R25]; [@R33]; [@R46]; [@R73]). In budding yeast, there are two well-characterized transcription-associated histone chaperones: facilitates chromatin transcription (FACT), which is composed of Spt16 and Pob3 (in conjunction with NHP6A/B) and Spt6, which function during transcription elongation ([@R6]; [@R24]; [@R27]; [@R32]; [@R37]; [@R39]; [@R56]; [@R69]).

Recent findings show that Spt6 directly binds to a phosphor-ylated linker domain in RNA polymerase II (RNAPII) via its tandem SH2 domain (tSH2) ([@R67]). In addition, studies from several laboratories find that Spt6 binds the serine 2 and/or tyro-sine 1 phosphorylated C-terminal domain (CTD) of RNAPII ([@R11]; [@R17]; [@R19]; [@R49]; [@R68]; [@R75]). Spt6 also binds histones and/or nucleosomes through its highly acidic (isoelectric point \[pI\] \~4.2) and unstructured N terminus to regulate chromatin structure ([@R6]; [@R56]). This acidic and unstructured region also binds Spn1 (interacts with SUPT6H \[IWS1\] in metazoans). Spt6 competes with Spn1 to bind to nucleosomes and prevent premature recruitment of the Swi/Snf complex during transcription elongation ([@R57]; [@R77]).

Based on its ability to bind phosphorylated RNAPII, Spt6 plays an important role in nucleosome deposition and the control of transcription-associated processes such as termination and mRNA export and/or stability ([@R2]; [@R22]; [@R55]; [@R74]). In addition to Spt6, the RNAPII elongation machinery is composed of other factors, including Spt4/5 (DSIF), the polymerase-associated factor complex (PAF-C), Spt2, Dst1/TFIIS, and the Ctk1 and Bur1 kinases. These kinases modify the CTD of RNAPII and (for Bur1) Spt5 ([@R13]; [@R21]; [@R45]; [@R76]). Casein kinase II (CKII) also co-purifies with Spt16, Spt6, and the RNAPII holoenzyme ([@R4]; [@R43]; [@R44]). Although studies have revealed a requirement for CKII during transcription initiation and elongation in mammalian and yeast cells ([@R3]; [@R8]), the function of CKII in these processes remains poorly understood.

We previously reported that CKII phosphorylates members of the PAF-C *in vivo* and *in vitro* and that this phosphorylation is essential for the maintenance of the global level of histone H2BK123 mono-ubiquitination (H2BK123ub1) ([@R4]). However, despite the presence of similar consensus CKII phosphorylation sites in other factors associated with transcription elongation (e.g., Spt6, Spt16, PAF-C, RNAPII holoenzyme) ([@R5]; [@R43]), it has not been determined whether these proteins are modified by CKII and how such modification functions in transcription elongation. In this article, we show that CKII phosphorylates multiple residues in the N terminus of Spt6, a region of Spt6 that interacts with H3/H4 and Spn1 ([@R6]; [@R57]). Mutation of these CKII phosphoacceptor sites in Spt6 to prevent phosphorylation (S→A, hereafter *spt6*~*S8*→*A8*~) resulted in reduced global nucleosome occupancy and aberrant anti-sense transcription from the 5^′^ ends of genes. An Spt6 mutant that mimics constitutive Spt6 phosphorylation (S→E, hereafter *spt6*~*S8*→*E8*~) largely rescued these phenotypes. These findings agree with a recent report that also characterized Spt6 phosphorylation by CKII ([@R29]). Mechanistically, we found that CKII phosphorylation of Spt6 mediates the full association of Spt6 with Spn1, which is required for nucleosome reassembly and for the recruitment of chromatin remodelers that aid in transcription elongation ([@R77]). Our results suggest that during transcription elongation, CKII phosphorylation of Spt6 facilitates the interaction with Spn1, which promotes nucleosome occupancy at the 5^′^ ends of genes to enforce the accuracy and directionality of transcription.

RESULTS {#S2}
=======

The N Terminus of Spt6 Is Phosphorylated by CKII {#S3}
------------------------------------------------

Recently, we characterized a protein interaction network involving CKII, FACT, PAF-C, and other members of the RNAPII transcription elongation complex ([@R4]). Our study revealed that CKII phosphorylates PAF-C members and regulates PAF-C-dependent H2BK123ub1. We also identified potential CKII phosphorylation sites in other co-associated transcription elongation factors (e.g., Spt16, Pob3, Spt2, Spt6), suggesting that CKII may also regulate the function of these proteins. We used a temperature-sensitive CKII strain (*cka1Δ cka2--8*, hereafter *ck2*^*ts*^) to determine whether other transcription-associated histone modifications would be affected under conditions of reduced CKII activity ([@R31]). As previously demonstrated, at the temperatures of 25°C and 37°C, the level of H2BK123ub1 in the *ck2*^*ts*^ strain was partially reduced ([@R4]; [@R34]), whereas there was no effect on the levels of H3 lysine 4 (H3K4) methylation or H3 lysine 79 (H3K79) methylation ([Figure S1A](#SD1){ref-type="supplementary-material"}). We also found that the disruption of CKII activity caused a reduction in global H3K36me3 levels ([Figure S1A](#SD1){ref-type="supplementary-material"}), suggesting that CKII activity regulates an aspect of the Spt6-Set2-H3K36me axis ([@R21]).

Because CKII and Spt6 co-purify, as had been reported ([@R43]), we hypothesized that CKII-mediated Spt6 phosphorylation may be important for H3K36 methylation. In agreement with Krogan et al., we confirmed the association of CKII with Spt6 in co-immunoprecipitation studies in which both CKII subunits, *CKA1* and *CKA2*, were hemagglutinin (HA) epitope tagged ([@R36]) and expressed in an FLAG-Spt6 strain ([Figure S1B](#SD1){ref-type="supplementary-material"}). Given this association, we inspected the Spt6 coding sequence for CKII phosphorylation consensus motifs (\[S/T\])XX\[D/E\]) ([@R31]). The acidic N terminus of Spt6 (amino acids \[aas\] 1--300) contains 8 consensus CKII sites ([Table S1](#SD2){ref-type="supplementary-material"} and see schematic in [Figure 1A](#F1){ref-type="fig"}). We then performed affinity purification of tandem affinity purification (TAP)-and FLAG-tagged Spt6 and subjected the purified proteins to mass spectrometry (MS) analysis and phosphopeptide mapping. We identified phosphorylation at multiple CKII consensus sites, primarily within the N terminus of Spt6 ([Figure 1A](#F1){ref-type="fig"}). Furthermore, our MS analysis also showed that these sites were not fully phosphorylated by CKII, indicating that Spt6 exists in both modified and unmodified forms. A comprehensive summary of these sites is presented in [Figure 1A](#F1){ref-type="fig"} and [Table S1](#SD2){ref-type="supplementary-material"}.

We next explored the extent to which phosphorylation at these sites in Spt6 would be altered by the absence of CKII. We performed quantitative proteomics and analyzed affinity purified FLAG-Spt6 from wild-type (WT) and *ck2*^*ts*^ cells after shifting the cells to restrictive temperatures to attenuate CKII activity ([Figure 1B](#F1){ref-type="fig"}). In brief, equal numbers of yeast cells were grown in media containing either light (*ck2*^*ts*^) or heavy (WT) arginine and lysine to perform stable isotopic labeling (also known as stable isotope labeling with amino acids in cell culture (SILAC) Arg10 Lys8; [@R14]). We performed quantitation using area under the curve measurements for the MS1 peak area for heavy and light peptides. Decreased phosphorylation was detected at multiple CKII consensus sites (S94, S134, and S136) ([Figure 1C](#F1){ref-type="fig"}). Phosphorylated Spt6 peptides ([Figure 1C](#F1){ref-type="fig"}, red dots) encompassing S134 and S136 showed a 1.3-fold decrease in the *ck2*^*ts*^ mutant, whereas unphosphorylated forms, shown as yellow dots, of the same peptides were enriched by \~4-fold in the *ck2*^*ts*^ mutant. Although we did not observe a large change in unmodified S94-containing peptides, S94-containing phosphopeptides decreased from 1.5- to just over 2-fold ([Figure 1C](#F1){ref-type="fig"}). Representative spectra of Spt6 phosphosites are shown in [Figures S2A--S2H](#SD1){ref-type="supplementary-material"}. These results provide strong evidence that Spt6 is a target of CKII phosphorylation *in vivo*.

To provide further evidence that CKII directly phosphorylates Spt6, we performed *in vitro* kinase assays using purified CKII enzyme, as described previously ([@R4]). These assays were performed with either a bacterially expressed N-terminal fragment of Spt6 that contains all of the CKII consensus sites (Spt6 1--300) or full-length FLAG-Spt6 purified from asynchronously growing yeast cells (FL Spt6). As controls for these experiments, mutant versions of recombinant and full-length Spt6 proteins were generated in which all eight consensus CKII sites were changed to alanine to prevent phosphorylation (Spt6~S8→A8~ 1--300 and FL Spt6~S8→A8~, respectively). Following incubation with 500 U CKII enzyme for 30 min at 30°C, we observed robust phosphorylation of the WT Spt6 fragment (1--300 aas), whereas the Spt6~S8→A8~ 1--300 mutant protein showed only background signal ([Figure 1D](#F1){ref-type="fig"}). The full-length WT and mutant versions of FLAG-Spt6 purified from yeast cells exhibited a similar difference ([Figure 1E](#F1){ref-type="fig"}). These results strongly imply that CKII is a bona fide kinase for Spt6, and furthermore, that all eight CKII consensus sites identified account for the majority, if not all, of the CKII-mediated Spt6 phosphorylation.

We next asked whether phosphorylation would have direct consequences on Spt6 protein stability. Cycloheximide chase experiments were performed in WT and *spt6* mutant strains in which we changed all eight CKII sites to alanine (*spt6*~*S8*→*A8*~). We found that Spt6 was degraded in WT cells within 2 hr, whereas the degradation kinetics were faster for the *spt6*~*S8*→*A8*~ mutant, occurring within 1 hr of cycloheximide treatment ([Figure 1F](#F1){ref-type="fig"}). The kinetics of WT Spt6 degradation were similar to that of an *spt6* mutant, in which all eight CKII sites were changed to glutamic acid to mimic phosphorylation (*spt6*~*S8*→*E8*~) ([Figure S2I](#SD1){ref-type="supplementary-material"}). These results suggest that CKII-mediated phosphorylation of Spt6 regulates protein stability, potentially by altering its ability to act as a chaperone.

To further understand the biological significance of these mutations under different physiological conditions, we subjected the WT, *spt6*~*S8*→*A8*~, and *spt6*~*S8*→*E8*~ strains to different growth conditions. We included as controls several previously characterized *spt6* mutant alleles, *spt6-tSH2Δ* and *spt6-F249K*. The *spt6-tSH2Δ* mutant is deficient in the tSH2 that mediates interaction with RNAPII, whereas the *spt6-F249K* mutant partially impairs the association of Spt6 with Spn1 ([@R11]; [@R57]). We also tested the *ck2*^*ts*^ strain ([@R31]). As previously shown, the *spt6-tSH2*D, *spt6-F249K*, and *ck2*^*ts*^ strains grew slowly at 30°C ([Figure 1G](#F1){ref-type="fig"}; [@R4]; [@R19]; [@R57]). The *spt6-F249K* and *ck2*^*ts*^ mutants failed to grow at an elevated temperature (37°C) and on plates containing the replication inhibitor hydroxyurea (HU) ([Figure 1G](#F1){ref-type="fig"}; [@R18]; [@R21]; [@R57]). In contrast, deletion of the tSH2 domain of Spt6 caused HU sensitivity, but it did not affect growth at 37°C ([Figure 1G](#F1){ref-type="fig"}; [@R19]).

Based on the foregoing phenotypes, we tested our *spt6*~*S8*→*A8*~ and *spt6*~*S8*→*E8*~ mutants at 37°C and in the presence of HU. Both mutant strains demonstrated growth patterns similar to WT at 30°C in yeast extract peptone dextrose (YPD) ([Figure 1H](#F1){ref-type="fig"}). At both 37°C and on plates containing HU, the *spt6*~*S8*→*A8*~ mutant showed a severe growth defect similar to the *spt6-F249K* and *ck2*^*ts*^ strains ([Figure 1G](#F1){ref-type="fig"}). Conversely, the *spt6*~*S8*→*E8*~ phospho-mimic mutant grew similarly to WT at 37°C or in the presence of HU ([Figure 1H](#F1){ref-type="fig"}). These results support an important functional role for CKII-mediated Spt6 phosphorylation. Furthermore, the HU phenotypes suggest that Spt6 may play a role in DNA replication or is important for the transcription of genes required for replication or cell-cycle control.

Finally, to ascertain whether all eight CKII phosphorylation sites were required to mediate the biological phenotypes observed in the *spt6*~*S8*→*A8*~ strain, we created two additional serine-to-alanine mutants in which either three or five of the CKII sites in Spt6 were mutated: *spt6*~*S3*→*A3*~, (S28, S39, and S40) and *spt6*~*S5*→*A5*~ (S94, S13, S144, S155, and S206). As shown in [Figure S2J](#SD1){ref-type="supplementary-material"}, the *spt6*~*S3*→*A3*~ mutant was completely insensitive to 37°C and 200 mM HU, whereas the *spt6*~*S5*→*A5*~ mutant showed intermediate sensitivity as compared with the *spt6*~*S8*→*A8*~ strain. These results imply that all eight identified CKII sites are required for the proper function of Spt6.

Because the turnover rate of Spt6 was increased in the *spt6*~*S8*→*A8*~ mutant ([Figure 1F](#F1){ref-type="fig"}), we also examined the steady-state protein levels generated from both the *spt6*~*S8*→*A8*~ and *spt6*~*S8*→*E8*~ mutants at a permissive temperature (30°C) and an elevated temperature at which the *spt6*~*S8*→*A8*~ mutant is lethal (37°C). Spt6 protein levels were similar to WT levels in both the *spt6*~*S8*→*A8*~ and *spt6*~*S8*→*E8*~ strains at the permissive temperature ([Figure 1I](#F1){ref-type="fig"}, lanes 2--4). However, at the restrictive temperature, we observed a partial decrease of the Spt6 protein level in the *spt6*~*S8*→*A8*~ mutant protein, but not in the *spt6*~*S8*→*E8*~ mutant ([Figure 1I](#F1){ref-type="fig"}, lanes 6--8). Consistent with a decrease in Spt6 levels, we also observed a subtle decrease in the Set2 protein and a decrease in H3K36me3 levels in the *spt6*~*S8*→*A8*~ mutant at the restrictive temperature, in agreement with our initial findings that CKII inactivation affects H3K36 methylation ([Figure S1A](#SD1){ref-type="supplementary-material"}).

CKII-Mediated Phosphorylation of Spt6 Is Required for Proper Nucleosome Occupancy {#S4}
---------------------------------------------------------------------------------

We next explored the influence of CKII-mediated Spt6 phosphorylation on nucleosome deposition. We performed chromatin immunoprecipitation sequencing (ChIP-seq) for histone H3 in our WT, *spt6*~*S8*→*A8*~, and *spt6*~*S8*→*E8*~ cells. H3 signal across all of the genes in WT cells demonstrated a center-weighted distribution with significant decreases at the transcriptional start sites (TSSs) and transcriptional termination sites (TTSs) ([Figures 2A and 2B](#F2){ref-type="fig"}). In contrast, H3 signal in the *spt6*~*S8*→*A8*~ mutant strain (and to a lesser extent in the *spt6*~*S8*→*E8*~ strain) was significantly diminished toward the 5^′^ ends of genes but increased at the 3^′^ ends (Figures [2A and 2B](#F2){ref-type="fig"}). We then asked whether this shift correlated with changes in Spt6 localization. Spt6 occupancy genome wide did not differ between WT and the *spt6* mutants ([Figures 2C and 2D](#F2){ref-type="fig"}) in the same way that H3 did, indicating that the defects observed in nucleosome occupancy are likely not to be the result of shifts in the localization of Spt6, but perhaps in its H3 deposition role.

Although the *spt6*~*S8*→*A8*~ mutant did not affect global Spt6 occupancy, further inspection of our Spt6 ChIP-seq dataset did in fact reveal a subset of genes with decreased localization of Spt6 at the 5^′^ ends without a change at their 3^′^ ends genes (n = 316) ([Figure S3A](#SD1){ref-type="supplementary-material"}). Histone levels across the same subset of 316 genes in the *spt6*~*S8*→*A8*~ mutant showed a corresponding nucleosome occupancy defect at the 5^′^ ends ([Figure S3B](#SD1){ref-type="supplementary-material"}), which is consistent with our global analysis of H3 levels ([Figures 2A and 2B](#F2){ref-type="fig"}). These findings were validated by ChIP-qPCR at two test genes: one within our group of 316 genes (*TDH3*; [Figure S3C](#SD1){ref-type="supplementary-material"}) and another just outside the significance threshold of this list (*PMA1*; [Figure S3D](#SD1){ref-type="supplementary-material"}) (see [Figures S3E--S3H](#SD1){ref-type="supplementary-material"} for the localization of Spt6 and H3). Further analysis of these 316 genes revealed that they were, on average, longer and more highly transcribed than the global mean ([Figures S3I and S3J](#SD1){ref-type="supplementary-material"}, respectively, red bars). Examination of the Gene Ontology (GO) terms associated with this subset did not reveal any clear enrichment of any pathways (data not shown). As an additional test, we identified genes in which Spt6 was increased at the 5′ end, rather than decreased, to see how they compared ([Figure S3C](#SD1){ref-type="supplementary-material"}). Fewer genes were identified (n = 298) using the same variance and signal cutoffs, and these genes showed no histone occupancy differences compared with WT cells. These genes were both shorter ([Figure S3K](#SD1){ref-type="supplementary-material"}) and expressed at lower levels compared with the global average ([Figure S3J](#SD1){ref-type="supplementary-material"}, blue bars), suggesting that the subtle Spt6 increases could come from lower overall Spt6 levels at these genes, resulting in higher variance and noise. Taken together, these results suggest an important role for phosphorylation of Spt6 by CKII in nucleosome deposition.

CKII-Mediated Phosphorylation of Spt6 Suppresses Antisense Transcription {#S5}
------------------------------------------------------------------------

Because of the shift in nucleosome occupancy in the context of the Spt6 phosphomutant, we next asked whether mutation of the Spt6 phosphoacceptor sites would affect antisense transcripts that are normally observed in the mutants of *SPT6* ([@R15]; [@R35]; [@R71]). Stranded RNA sequencing (RNA-seq) analysis (with spike-in controls for normalization) was performed in WT, *spt6*~*S8*→*E8*~*, spt6*~*S8*→*A8*~, and *spt6--1004* strains. Looking at global levels of antisense transcription expression (via transcripts per kilobase million), the *spt6--1004* allele caused drastic changes in antisense transcription, a result that is consistent with previous studies ([Figure 3A](#F3){ref-type="fig"}, *r*^2^ = 0.787) ([@R71]). A comparison of antisense transcripts between the *spt6*~*S8*→*A8*~ *and spt6*~*S8*→*E8*~ mutants with the WT profile showed that although the *spt6*~*S8*→*A8*~ mutant exhibited some increase in antisense transcription (*r*^2^ = 0.959), the *spt6*~*S8*→*E8*~ mutant showed minimal change in antisense transcription ([Figure 3A](#F3){ref-type="fig"}, *r*^2^ = 0.977) ([Table S5](#SD6){ref-type="supplementary-material"}). Further analysis of our RNA-seq data showed broad sense transcription defects in the *spt6--1004* allele, although less so for the *spt6*~*S8*→*A8*~ mutant ([Figure S4A](#SD1){ref-type="supplementary-material"}).

Closer inspection of our RNA-seq datasets for antisense transcripts showed us that there were 914 unique antisense transcripts across 829 genes in the *spt6--1004* mutant relative to WT ([Figure 3B](#F3){ref-type="fig"}). The *spt6*~*S8*→*A8*~ strain also demonstrated an increase in the number of unique antisense transcripts relative to WT (52 transcripts across 40 genes), and \>50% of these transcripts overlapped with the unique antisense transcripts predicted in the *spt6--1004* mutant (34 of 52 transcripts, although all 40 genes overlapped) ([Figure 3B](#F3){ref-type="fig"}). In stark contrast to the *spt6*~*S8*→*A8*~ mutant, the *spt6*~*S8*→*E8*~ mutant showed few to no unique antisense transcripts (n = 4) ([Figures 3A and 3B](#F3){ref-type="fig"}). Antisense RNA signal at genes with antisense transcripts detected in the *spt6--1004* allele and *spt6*~*S8*→*A8*~ mutants demonstrated a strong 5′ end bias ([Figure 3C](#F3){ref-type="fig"}). This 5^′^ end antisense bias was confirmed in several ways. Antisense levels of the highlighted 40 *spt6*~*S8*→*A8*~ genes between the 5^′^ and 3^′^ halves were compared. The 5^′^ half of the genes had significantly more antisense signal than the 3^′^ half (p \< 0.0001, Wilcoxon rank-sum; [Figure 3D](#F3){ref-type="fig"}). On a per-gene basis, the 5^′^ and 3^′^ half ratios (log~2~) were plotted. A total of 80% of the genes had a higher 5^′^ signal relative to the 3^′^ half of the genes ([Figure 3E](#F3){ref-type="fig"}). We also compared the antisense transcript signal for the 829 genes detected in the *spt6--1004* mutant. Consistent with the 40 highlighted genes, the 5^′^ halves had significantly more anti-sense signal relative to the 3^′^ halves (p \< 0.0001, Wilcoxon rank-sum; [Figure 3F](#F3){ref-type="fig"}). Again, the 5^′^ and 3^′^ half ratios were calculated for each of the 829 genes. Of the genes, 80.6% (668) had a higher signal in the 5^′^ half of the gene. The increased antisense RNA signal detected at the 5^′^ end of genes in both the *spt6--1004* and *spt6*~*S8→A8*~ is consistent with the decreased nucleosome occupancy observed in the absence of CKII phosphorylation of Spt6 ([Figures 2A](#F2){ref-type="fig"}, [S3G, and S3H](#SD1){ref-type="supplementary-material"}). Two examples of this finding are shown in [Figures 3H and 3I](#F3){ref-type="fig"}, which show high levels of antisense transcription emerging from the 5^′^ ends of the *SMY1* and *YTA6* loci. The *spt6*~*S8→E8*~ and WT strains did not exhibit high levels of antisense transcription ([Figures 3H and 3I](#F3){ref-type="fig"}).

We further validated the occurrence of these antisense transcripts by strand-specific quantitative real-time PCR and determined whether they would be associated with nucleosome decreases at their 5′ ends. As predicted, the levels of *SMY1* and *YTA6* antisense transcripts were elevated in *spt6--1004* and *spt6*~*S8*→*A8*~ mutants compared with WT ([Figures S4B and S4C](#SD1){ref-type="supplementary-material"}). The *spt6*~*S8*→*E8*~ strain showed a slight increase in the *YTA6* anti-sense transcript, but no increase of the *SMY1* antisense transcript, as compared to WT. These observations support a model in which phosphorylation of Spt6 by CKII plays an important role in the maintenance of chromatin structure at the 5^′^ ends of genes. These findings are in agreement with those of [@R63] in which artificial depletion of Spt6 using a temperature degron (*td*) caused preferential loss of nucleosomes from the 5^′^ ends of genes. Given the acute loss of Spt6 results in similar findings, as observed in our *spt6* mutants, the collective results strongly argue a critical role for Spt6 in nucleosome deposition at the 5^′^ ends of genes. These findings also imply that Spt6 is not essential for nucleosome deposition at the 3^′^ ends of genes, which we speculate may be a function that is more dependent on FACT.

CKII-Mediated Phosphorylation of Spt6 Suppresses Sense Cryptic Transcription and Maintains Genome Integrity {#S6}
-----------------------------------------------------------------------------------------------------------

In addition to preventing antisense transcription, Spt6 is known to suppress cryptic transcription---in other words, sense transcripts that initiate aberrantly within the bodies of genes ([@R9]). We therefore asked whether the inability of CKII to phosphorylate Spt6 would result in increased cryptic transcription. To initially address this question, we examined two cryptic transcription-prone genes, *STE11* and *SPB4* ([@R9]) ([Figures S4D and S4E](#SD1){ref-type="supplementary-material"}) using quantitative real-time PCR to quantify cryptic transcription ([@R22]; [@R38]). As shown previously, the *spt6--1004* cells ([Figures S4F and S4G](#SD1){ref-type="supplementary-material"}) and *spt6*~*S8*→*A8*~ ([Figures S4H and S4I](#SD1){ref-type="supplementary-material"}) cells showed an \~5-fold increase in the 3^′^ RNA levels (i.e., cryptictranscription) arising at the *STE11* and *SPB4* loci. In WT and the *spt6*~*S8*→*E8*~ cells, however, the 5^′^ to 3^′^ RNA levels at these genes were unaffected ([Figures S4H and S4I](#SD1){ref-type="supplementary-material"}). Consistent with the sense cryptic transcription, ChIP-qPCR for H3 revealed a significant reduction in nucleosome density at the 3^′^ ends of the *STE11* and *SPB4* genes (68% and 72%) in the *spt6*~*S8*→*A8*~ mutant strain but not in the *spt6*~*S8*→*E8*~ mutant ([Figures S4J and S4K](#SD1){ref-type="supplementary-material"}).

The *SRG1-SER3* gene expression system is another well-established system to monitor the impact of chromatin integrity on proper gene transcription ([Figure 4A](#F4){ref-type="fig"}; [@R30]; [@R52], [@R53]). When cells are cultured in the presence of serine, expression of *SRG1* causes transcriptional interference and repression of *SER3*. When serine is deprived, *SRG1* transcription is attenuated, removing transcriptional interference and increasing *SER3* expression. However, the mutation of factors that affect chromatin integrity, such as *SPT6*, causes derepression of *SER3* independent of *SRG1* (due to the loss of nucleosome occupancy at the *SRG1* locus) ([@R61]; [@R70]). Therefore, we examined the potential of the *spt6*~*S8→A8*~ and *spt6*~*S8*→*E8*~ mutants to bypass the normal regulation of the *SRG1-SER3* system. As expected, and consistent with the established role of Spt6 in maintaining *SER3* repression, we found that *SER3* levels were upregulated in the *spt6--1004* allele and *spt6*~*S8*→*A8*~, whereas the level of derepression was lower in the *spt6*~*S8*→*E8*~ mutant ([Figure 4B](#F4){ref-type="fig"}). We used DESeq2 to determine the differential RNA abundance between genes. *SER3* expression was calculated to be significantly more abundant in the mutants compared to WT (WT to *spt6*~*S8*→*E8*~, p ≤ 9.31 × 10 ^−\ −17^, 6.7-fold increase; WT to *spt6*~*S8*→*A8*~, p ≤ 4.81 × 10 ^−30^, 11.0-fold increase; WT to *spt6--1004*, p ≤ 5.85 × 10 ^−57^, 26.1-fold increase). In fact, of all of the possible pairwise *SER3* RNA abundance comparisons, the only pairwise set that was not observed to be significantly different was between *spt6*~*S8*→*E8*~ and *spt6*~*S8*→*A8*~. We confirmed the increase in the expression level of *SER3* in the *spt6--1004* and *spt6*~*S8*/*A8*~ mutant by quantitative real-time PCR ([Figures 4C and 4D](#F4){ref-type="fig"}, respectively). As predicted from these findings, the *spt6*~*S8*→*A8*~ mutant caused a loss of nucleosome occupancy at the *SRG1* locus ([Figure 3E](#F3){ref-type="fig"}). Conversely, in the *spt6*~*S8*→*E8*~ mutant, both increased *SER3* expression and nucleosome occupancy at *SRG1* were largely unaffected ([Figures 4D and 4E](#F4){ref-type="fig"}, respectively). These results show that the CKII phosphorylation of Spt6 is required for nucleosome deposition and chromatin integrity to maintain stringent control of gene transcription.

Spt6-Spn1 Interaction Is Regulated by CKII-Dependent Phosphorylation of Spt6 {#S7}
----------------------------------------------------------------------------

Spt6 co-purifies with a variety of transcription-associated proteins, including histones, RNAPII, and Spn1 ([@R43]). To determine which of these interactions, if any, would be affected by CKII phosphorylation, we affinity purified FLAG-tagged Spt6 (n = 4) and FLAG-tagged *spt6*~*S8*→*A8*~ (n = 4) and analyzed the purified complexes by MS. Significance analysis of interactome (SAINT) was performed to obtain protein-protein interaction probabilities for the MS results obtained from FLAG-tagged strains relative to each other and untagged controls (n = 4) ([@R10]) ([Figure 5A](#F5){ref-type="fig"}). Compared with WT spt6, the association of Spn1 with Spt6 in the *spt6*~*S8*→*A8*~ mutant was reduced by \~50% ([Figure 5B](#F5){ref-type="fig"}), suggesting that Spt6 phosphorylation controls Spn1 association. In contrast, Spt6 interactions with histone and RNAPII were not disrupted by the mutation of CKII sites (Figures [5B](#F5){ref-type="fig"} and [S5A](#SD1){ref-type="supplementary-material"}). A full list of the differential interactions identified is provided in [Table S6](#SD1){ref-type="supplementary-material"}. In support of the MS results, the Spt6-Spn1 interaction was reduced in the *spt6*~*S8*→*A8*~ mutant strain without any effect in the *spt6*~*S8*→*E8*~ mutant by co-immunoprecipitation and immunoblot probing for Spn1 (Figures [5C](#F5){ref-type="fig"} and [S5B](#SD1){ref-type="supplementary-material"}). Finally, when we treated immuno-precipitated Spn1 (or reciprocally immunoprecipitated Spt6) with lambda phosphatase (on beads) before immunoblotting, the interaction between Spn1 and Spt6 decreased drastically, a result that further confirmed the phospho-dependence of the Spt6-Spn1 interaction (Figures [5D](#F5){ref-type="fig"} and [S5C](#SD1){ref-type="supplementary-material"}).

Because phosphorylation of Spt6 by CKII is required for proper Spt6-Spn1 interaction, we next asked whether mutations in *SPN1* that perturb its interactions with Spt6 (e.g., *spn1-R263D*, *spn1-F267E*) ([@R57]) would phenocopy the *spt6*~*S8*→*A8*~ mutant. Both *spn1* mutants were associated with decreased RNAPII Ser2 CTD phosphorylation and H3K36 methylation ([Figure S6A](#SD1){ref-type="supplementary-material"}). In addition, we found that the *spn1-F267E* mutant that affects Spt6-Spn1 interaction similar to the *spt6*~*S8*→*A8*~ mutant ([Figures 4B and 4C](#F4){ref-type="fig"}) resulted in derepression of *SER3* in the *SRG1-SER3* system ([Figure S6B](#SD1){ref-type="supplementary-material"}). A similar result was observed in the context of a mutation in Spt6 that perturbs Spn1 interaction (*spt6-F249K*) ([Figure S6C](#SD1){ref-type="supplementary-material"}). Furthermore, the *spt6-F249K, spn1-R263D*, and *spn1-F267E* mutants phenocopied the *spt6*~*S8*→*A8*~ mutant to different degrees with respect to their sensitivity to heat and 200 mM HU ([Figure 5E](#F5){ref-type="fig"}, top). Based on these observations, we created a double mutant of *spt6*~*S8*→*A8*~ with *spn1-R263D* to examine the consequence of combining orthogonal mutants that impair Spt6-Spn1 interaction. This double mutant was synthetically sick under normal growth conditions, and it was lethal either at 37°C or in the presence of 200 mM HU ([Figure 5E](#F5){ref-type="fig"}). These findings agree with those of [@R57], in which orthogonal mutants of Spt6 and Spn1 disrupt Spn1-Spt6 interaction (i.e., *spt6-F249K + spn1-F267E* and *spt6-F249K + spn1-R263D*). Finally, further examination of this double mutant revealed decreases in H3K36 methylation and RNAPII levels, suggesting that the interaction between Spt6 and Spn1 is also crucial for Spt6-Ctk1-Set2 regulation ([Figure 5F](#F5){ref-type="fig"}).

DISCUSSION {#S8}
==========

Spt6 deposits nucleosomes in the wake of elongating RNAPII, and a lack of functional Spt6 causes open chromatin regions ([@R9]; [@R35]); however, the mechanisms that regulate Spt6 function are largely unknown. Although multiple enzymes associate with RNAPII during transcription initiation and/or elongation, the activities of these enzymes on the full RNAPII elongation complex have not been fully explored. Here, we show that CKII phosphorylates Spt6 to promote nucle osome reassembly and chromatin stability, which are required for proper transcriptional regulation. Using SILAC-based MS, we confirmed that Spt6 is phosphorylated by CKII at multiple N-terminal sites, a region of Spt6 that interacts with histones and Spn1 ([@R56]; [@R57]). Furthermore, we establish that Spt6 phosphorylation by CKII is important for proper nucleosome occupancy at nearly all RNAPII transcribed genes and find this role to be particularly important at the 5^′^ ends of genes. Consistent with this finding, mutants of *spt6* that cannot be phosphorylated show elevated levels of antisense transcription originating from the 5^′^ ends of genes. Mechanistically, we show that Spt6 phosphorylation is required for proper Spt6-Spn1 interaction, which we suggest plays a role in regulating the ability of Spt6 to deposit nucleosomes and enforce directionality of RNAPII, as represented in [Figure 6](#F6){ref-type="fig"}.

A major observation from our study is the role that CKII-dependent phosphorylation of Spt6 plays in regulating the levels of nucleosomes along genes. Our studies found that the prevention of Spt6 phosphorylation by CKII leads to the depletion of histone H3 (a proxy for nucleosome occupancy) at the 5^′^ ends of genes, with a corresponding increase in H3 at their 3^′^ ends ([Figures 2A and 2B](#F2){ref-type="fig"}). The widespread decrease of nucleosomes we observed may be due to the fact that phosphorylated Spt6, and the stabilized interaction of Spn1 it directs, is important for 5^′^ end nucleosome reassembly during transcription. In the absence of phosphorylated Spt6, nucleosomes appear to build up at the 3^′^ end due to RNAPII transcription moving, and thereby compacting, nucleosomes toward the 3^′^ ends of genes. Another possibility that is not mutually exclusive to the idea above, is that phosphorylated Spt6 maintains nucleosomes at the 5^′^ ends by recruiting and/or activating the machinery that prevents active histone exchange. One such mechanism that prevents histone exchange is Set2, whose function is intertwined with the presence of functional Spt6 ([@R21]; [@R76]). Our results show that CKII-dependent phosphorylation of Spt6 affects Set2-dependent H3K36 methylation (Figures [S1A](#SD1){ref-type="supplementary-material"} and [1I](#F1){ref-type="fig"}). Consistent with the loss of nucleosomes in the *spt6*~*S8*→*A8*~ mutant at the 5^′^ ends of genes, we also observed an increase in sense and antisense cryptic transcription, an effect that was more pronounced at the 5^′^ ends of genes.

It is important to note that while this article was in revision, [@R29] also reported that Spt6 is phosphorylated by CKII, and they showed that this phosphorylation contributes to the suppression of cryptic transcription. These authors demonstrated that the increase in cryptic transcription was attributed to an increase in histone exchange in the context of *ck2*^*ts*^ and in *spt6* mutants that cannot be phosphorylated, a result that is consistent with our findings of the *spt6*~*S8*→*A8*~ mutant having nucleosome occupancy changes. Thus, there is a great deal of agreement between these two studies.

One key mechanistic finding of our study is the importance of CKII phosphorylation to maintain Spt6-Spn1 interaction. Spn1/IWS1 is a binding partner of Spt6, and heretofore, we did not suspect the existence of a mechanism that maintains the association or the broad effects of Spt6-Spn1 heterodimerization on chromatin ([@R26]; [@R43]). Because Spn1 binding occurs in close proximity to the N-terminal CKII phosphorylation sites (aas 239--268) ([Figure 1A](#F1){ref-type="fig"}), we hypothesized that Spn1 binding to Spt6 is regulated or fine-tuned by CKII phosphorylation. It may be that an increased acidity of N-terminal phosphorylated Spt6 promotes Spn1 binding, or alternatively, Spt6 phosphorylation may eliminate an intramolecular inhibitory interaction to make the Spn1 binding site accessible. Although proof of such an autoinhibitory mechanism is beyond the scope of this study, such a mechanism exists for other histone chaperones, such as Spt2 and HJURP, that are modified post-translationally to release inhibitory states to regulate histone binding ([@R72]). [@R48] also showed that full-length Spn1 interacts with DNA, histone H3/H4, mononucleosomes, and nucleosomal arrays, and that Spn1 has a weak nucleosome deposition activity. Thus, phosphorylation-mediated interaction of Spn1 with the Spt6 N terminus could have effects on the overall function of Spt6, partly mediated by the decreased stability and its ability to interact with RNAPII or other factors.

In addition to regulating the Spt6-Spn1 association, CKII phosphorylation of Spt6 may affect chromatin integrity by affecting the interaction between Spt6 and Spt2 ([@R5]). However, we have not found that deletion of *SPT2* affects Set2/H3K36me levels (unpublished data), indicating that the effects of the *ck2*^*ts*^ mutation on Spt6, Set2, and H3K36me levels are not simply due to the absence of the Spt6-Spt2 interaction. In addition, our extensive MS analyses and co-immunoprecipitation experiments showed that the *spt6*~*S8*→*A8*~ mutation did not affect the ability of Spt6 to interact with RNAPII ([Figure S5A](#SD1){ref-type="supplementary-material"}). Thus, the major consequence of CKII phosphorylation of Spt6 is to maintain Spn1 association. Future studies are required to precisely determine the mechanistic basis of this interaction and how it contributes to nucleosome reassembly.

Finally, it is important to mention that the function of CKII in transcriptional regulation and chromatin maintenance is likely to be highly conserved. Other investigators have documented an important function of CKII in transcriptional regulation from yeast to humans ([@R3]), and the N terminus of human Spt6 (SUPT6H) has similar consensus CKII phosphorylation sites that are phosphorylated (summarized at <https://www.phosphosite.org>). Thus, it will be important to determine the extent to which CKII phosphorylation of SUPT6H contributes to chromatin reassembly and transcriptional fidelity.

STAR★METHODS {#S9}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S11}
----------------------------------------

Further information and requests for resources and reagents should be directed to, and will be fulfilled by, the Lead Contact, Brian D. Strahl (<brian_stral@med.unc.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

All yeast strains are listed in [Table S2](#SD3){ref-type="supplementary-material"}. Gene deletions and C-terminal epitope tagging of endogenous genes were performed by gene replacement ([@R28]; [@R36]). Plasmids used in this study are listed in [Table S3](#SD4){ref-type="supplementary-material"}. Mutagenesis of pRS306-FLAG-SPT6, a gift from Fred Winston, Harvard Medical School, Boston, MA, ([@R39]) ([Table S2](#SD3){ref-type="supplementary-material"}) was performed with the QuickChange Lightning Multi Site-Directed Mutagenesis Kit (Agilent Technologies) and primers described in [Table S4](#SD5){ref-type="supplementary-material"}. Plasmids were verified by Sanger sequencing prior to transformation of yeast by a standard two-step gene replacement method. All yeast strains were verified by PCR amplification of genomic DNA, Sanger sequencing, and immunoblotting for epitope-tagged proteins (primers are listed in [Table S4](#SD5){ref-type="supplementary-material"} and antibodies are described below).

METHOD DETAILS {#S13}
--------------

### SILAC methodology {#S14}

WT Spt6--3XFLAG strains were cultured in complete minimal medium containing L-Lysine (^13^C~6~, ^15^N~2~) and L-Arginine (^13^C~6~, ^15^N~4~), which produce +8 and +10 dalton mass shifts, respectively. CKII mutant strains were cultured in complete minimal medium with light amino acids (specifically L-Lysine (^12^C~6~, ^14^N~2~) and L-Arginine (^12^C~6~, ^14^N~4~). Following cell pelleting and washing, cells were mixed at a 1:1 (wt/mutant) ratio and resuspended in TAP lysis buffer. Lysis was performed as described ([@R4]). Purification efficiency was assessed by silver staining a TGX SDS-PAGE gel (Bio-Rad) prior to trichloroacetic acid precipitation of the Spt6-FLAG elutions. Protein pellets were resuspended in 8 M urea in 100 mM Tris-HCl (pH 8.5). Proteolytic digestions were performed with LysCTrypsin Gold (Promega), quenched, and pressure loaded onto a three-phase multidimensional protein identification technology (MudPIT) column ([@R60]). Samples were analyzed by 10-step MudPIT on an Orbitrap Fusion Lumos mass spectrometer. Two technical replicate analyses were performed with either collision induced dissociation-based fragmentation or a combination of higher energy collision dissociation (HCD) and electron transfer dissociation with supplemental HCD activation. The resulting raw data were searched using SEQUEST HT in Proteome Discoverer 2.1 (Thermo) and quantitation was performed using built-in SILAC 8,10 quantitation mode for MS1 precursor intensity-based quantitation.

### Affinity-purification and co-immunoprecipitations {#S15}

Spt6-FLAG purifications from WT, mutant, or parental cells were performed as previously described from 6 L of asynchronous log phase grown yeast ([@R4]). Following cryolysis, clarification, and incubation with anti-FLAG M2 agarose beads (Sigma-Aldrich); the beads were extensively washed with TAP lysis buffer before purified protein elution through incubation with a 10-fold excess of 3X FLAG peptide. Samples were digested with trypsin as described above and then analyzed by 10-step MudPIT on a Velos Pro Orbitrap mass spectrometer. Following database search against a yeast Uniprot fasta database, peptide-spectrum matches were used for SAINT analysis as previously described ([@R4]; [@R7]; [@R10]; [@R58]).

Co-immunoprecipitations were performed as described ([@R59]) with minor modifications. Overnight saturated yeast cultures were inoculated into 100 mL fresh YPD at an optical density 600 (OD~600~) of about 0.2. Cells were grown to an OD~600~ of approximately 1--1.2, washed with water, and suspended in buffer containing 450 mM Tris-acetate (pH 7.8), 150 mM potassium acetate, 60% (v/v) glycerol, 3 mM EDTA (pH 8.0), and supplemented fresh with 3 mM DTT, 1 mM PMSF, 1X complete EDTA-free protease inhibitors (Roche). Suspended cells were lysed with glass beads using a mini bead beater (Disruptor Genei) for 10 minutes at 4°C, with 1 minute on and 1 minute off cycle in the cold room after which cells were allowed to rest for 10 minutes at 4°C, and then cleared by centrifugation for 15 minutes 4°C. Protein concentrations of lysates were estimated using a Bradford Protein Assay (Bio-Rad). One mg of total protein was incubated in 1 mL of buffer A \[50 mM HEPES-KOH (pH 7.5), 1 mM EDTA (pH 8.0), 20% (v/v) glycerol, 125 mM potassium acetate, 1% (v/v) NP-40, supplemented fresh with 100 mM DTT\] containing 30 ml of anti-FLAG M2 agarose (Sigma-Aldrich) overnight at 4°C. Next day, beads were washed 5 times in buffer A and protein complexes were eluted using 3X-FLAG peptide (Sigma) following the manufacturer's instructions. Proteins were separated by SDS-PAGE and subjected to immunoblotting to detect interacting proteins (antibodies are listed below). To study phospho-dependent interactions, FLAG-Spt6-bound beads were treated with 200 U of lambda phosphatase for 30 minutes at 30°C. After incubation, beads were washed twice with buffer A and heated at 95°C in SDS loading buffer. For every co-immunoprecipitation, 10% input was applied to the gels.

### Recombinant Spt6 and Spn1 expression and purification {#S16}

The N-terminal fragments of WT, *spt6*~*S8*→*A8*~ mutants (aa1--300) and structured region of Spn1 (aa 141--405) were cloned in *pET28a* as 6X-HIS tagged fragments. Plasmids were sequenced to confirm the orientation and the existence of *spt6*~*S8*→*A8*~ mutation before progressing with purification. Recombinant proteins were purified as described elsewhere. Briefly, plasmids were transformed into SoluBL21 cells and log phase cultures of bacteria were induced with 1mM IPTG at 16°C overnight. Next day, cells were centrifuged and lysates were prepared in lysis buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 20 mM imidazole, pH to 8.0, 1 mg/ml Lysozyme, 2 microL/ml Universal Nuclease and 1% Triton X-100) containing 20 mM imidazole and applied to Ni-NTA agarose columns. Lysate was incubated with beads for 2h at 4°C and subjected to six washes with wash buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 20 mM imidazole, pH to 8.0). Proteins were eluted in wash buffer containing 300mM imidazole and dialyzed overnight in wash buffer containing 20 mM imidazole. Protein concentrations were estimated using Bradford reagent.

### *In vitro* kinase assays {#S17}

*In vitro* kinase assays were performed as described previously ([@R4]). Briefly, the bacterially expressed and purified fragments of Spt6 and the full length Spt6 purified from asynchronously growing yeast cells was incubated either alone or with 500 Units of CKII enzyme. The reactions were carried out in the kinase buffer (40 mM HEPES \[pH 7.5\], 10 mM MgCl2, 5 mM dithiothreitol, and 10 mCi of \[γ-32P\]-ATP) (6000Ci/mmol; Perkin Elmer) for 2hrs at 30°C. Reactions were stopped by adding SDS-PAGE loading buffer. Samples were boiled for 10 minutes and subjected to SDS-PAGE, dried, and exposed to film for autoradiography.

### Cycloheximide chase assays {#S18}

Cycloheximide chase assays were performed to ascertain the turnover of Spt6 in the WT and *spt6*~*S8*→*A8*~ mutants as described previously ([@R21]). Briefly, strains were grown in a special synthetic complete (SC) media that contained 0.1% proline as a source of nitrogen. Yeast strains of indicated genotypes grown overnight were diluted to an OD~600~ of 0.2 and allowed to grow until they reached an OD~600~ of 1 in the presence of 0.003% SDS. Cells were collected at various time points and fixed and lysed in 10% trichloroacetic acid (TCA as described elsewhere ([@R41], [@R42]). Proteins were separated by SDS-PAGE and immunoblotted using antibodies specific for indicated proteins.

### Immunoblotting {#S19}

Yeast strains of the indicated genotypes (and their wild-type counterparts) were grown in YPD either at permissive or restrictive temperatures. Overnight-saturated cultures were diluted to an OD~600~ of 0.2 and allowed to grow until they reached an OD~600~ of 1. Five OD~600~ equivalents of cells were lysed using a modified TCA extraction method as described ([@R41], [@R42]). 10--20 mg of the lysates were separated by SDS-PAGE and variously probed with the following antibodies: anti-FLAG-M2 \[for FLAG tagged Spt6\] (Sigma-Aldrich, F1804; 1:5000), anti-G6PDH (Sigma-Aldrich, A9521; 1:100,000), anti-histone H3K4me3 (EpiCypher, 13--0004; 1:5000), anti-histone H3K79me3 (Abcam, ab2651, 1:2500) anti-histone H3K36me3 (Abcam, ab9050, ab9050; 1:1000), anti-histone H3 (EpiCypher, 13--0001; 1:50,000), anti-Spt16 (gift from Tim Formosa University of Utah, 1:5000), anti-H3K36me2 (Active Motif, 39255; 1:1000), anti-Set2 (Generated in the Strahl lab, 1:5000), anti-RNAPII-Ser2P (Active Motif, Clone \#3E10, 61084; 1:100), anti-H2BK123ub1 (Cell Signaling Technology, 5546; 1:2000), and anti-H2B (Active Motif, 39237; 1:2000). HRP-conjugated anti-rabbit (GE Healthcare, NA934V; 1:10,000) and anti-mouse secondary (GE Healthcare, NA931V; 1:10,000), antibodies were used at 1:1000 and proteins were detected using ECL Prime or enhanced chemiluminescence ECL (Amersham Biosciences).

### Spotting assays {#S20}

Spotting assays were used to assess the sensitivities of the yeast strains to drugs and temperature changes. Saturated yeast cultures of the indicated genotypes were diluted to an OD~600~ of 0.2, followed by a five-fold serial dilution, and spotted on plates with or without 200 mM hydroxyurea (HU). Growth was assessed after 3 days at 30°C or 37°C. Every experiment was performed at least three times and the representative images are shown.

### RNA extraction and real-time quantitative PCR {#S21}

Yeast cell RNA was extracted using a hot acid phenol method ([@R12]). The isolated RNA was treated with 10 U of RNase-free DNase (Promega) for 30 minutes, followed by RNA cleanup (QIAGEN RNeasy Mini Kit, 74106). cDNA was synthesized from one mg of total RNA using random hexamer primers and Superscript Reverse Transcriptase III (Thermo-Fisher Scientific, 108--80044). The cDNA was diluted 1:25 before being subjected to real-time PCR (primers shown in [Table S4](#SD5){ref-type="supplementary-material"}). Quantitative real-time PCR was performed using the SYBR Green Master mix according to manufacturer's instructions (Bio-Rad, 1725270), and the relative quantities of transcripts were calculated using the ΔΔC~t~ method ([@R50]) and *ACT1* or *PGK1* as controls. The data shown are the replicates of three independent experiments with three technical replicates in each experiment, and the significance values were calculated using Student's t test.

### Chromatin immunoprecipitation {#S22}

ChIP was performed as described with modifications ([@R1]). The DNA from the pull-downs was estimated using quantitative real time PCR (primers described in [Table S4](#SD5){ref-type="supplementary-material"}). Data are mean of % input values ± the standard deviations from three biological replicates with three technical replicates in each experiment. Significance values were calculated using Student's t test.

### RNA-seq methodology and data analysis {#S23}

RNA was extracted using acid-phenol method ([@R12]) and was quantified spectrophotometrically. 2.5 μg of total RNA was used to deplete rRNA using the Ribo-zero kit (Illumina). ERCC spike-in controls were added to the RNA samples after rRNA clean-up and before proceeding on to the library preparation. Stranded RNA-seq libraries were prepared using TruSeq Stranded Total RNA sample preparation according to manufacturer's instructions. The libraries were sequenced on Illumina HiSeq 2500, paired-end 50bp reads). RNA-seq reads were first trimmed for possible adaptor contamination using cutadapt (v1.10), ([@R54]) with the recommended sequence for Illumina adapters as well as a minimum read length of 36 base pairs (bp). Low quality reads were then filtered with fastq_quality_filter, a function within the fastx-toolkit (v0.0.14), with command line options -p 90 and -q 20 to keep reads with at least a 20 Phred score at a minimum of 90% of the bases. Reads were then aligned to the sacCer3 genome using STAR (v2.5.2b), ([@R20]) and the following options:--quantMode TranscriptomeSAM,--outFilterMismatch Nmax 2,--alignIntronMax 1000000,--alignIntronMin 20,--chimSegmentMin 15,--chimJunctionOverhangMin 15,--outSAMtype BAM Un-sorted,--outFilterType BySJout,--outFilterScoreMin 1, and--outFilterMultimapNmax 1. A GTF file was given for the--sjdbGTFfile option that was generated in house combining the sacCer3 RefSeq and ERCC spike-in GTFs. Finally, the Salmon (v0.8.1), ([@R62]) function quant was used to quantify RNA counts over each gene, and DESeq2 (v1.14.1), ([@R51]) was used to calculate differential genes (adjusted p value ≤ 0.05).

Stranded RNA-seq allows us to map reads to specific strands, so all aligned reads were assigned sense or antisense based on whether they overlapped sacCer3 RefSeq genes in the same or opposite strand, respectively. Reads that didn't overlap any gene were discarded for any stranded analyses as we couldn't confidently assign them sense/antisense. Unfortunately, overlapping genes cause reads to be assigned to both sense and antisense, so regions of gene overlap plus 49bp on either side (to account for read length) were subtracted out using bedtools (v2.26), ([@R64]), and expression of the remaining regions was re-quantified and run through DESeq2 to determine differential genes (adjusted p value ≤ 0.05). Antisense cryptic transcripts were identified using previously published methods with no changes except using a minimum of 0.5 RPKM versus their previous minimum of 4.0 FPKM ([@R16]). File conversions were done with samtools (v1.3.1, ([@R47])) and in-house scripts.

Reads were initially aligned and processed as paired end fragments, however signal tracks demonstrated an unusual pile-up of reads at specific and consistent locations across the gene that only occurred in the "R1" reads. To eliminate potential biases this may have added to downstream analyses, we only used the "R2" reads in this work. As no global transcriptional changes were observed using the ERCC spike-in, ERCC reads were removed from the dataset and not used for downstream analysis or quantification.

To examine the antisense signal over genes, Deeptools (v2.5.4) ([@R65]) tool computeMatrix in reference-point mode was used (with options -bs 1, and--nanAfterEnd) to calculate a per-base signal track of antisense RNA-seq signal. R ([@R66]). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <https://www.R-project.org/>) was used for the 5^′^-half and 3^′^-half calculations, and R function 'heatmap.2^′^ in the 'gplots' (<https://cran.r-project.org/web/packages/gplots/index.html>) library was used to plot the signal in the heatmap (in order of gene length). Base R was used unless stated otherwise.

### ChIP-seq methodology and data analysis {#S24}

Libraries for the ChIP seq were prepared using Kappa hyper prep kit using manufacturer's instructions. ChIP-seq reads were first trimmed for possible adaptor contamination using cutadapt (v1.10), ([@R54]) with the recommended sequence for Illumina adapters as well as a minimum read length of 36 base pairs (bp). Low quality reads were then filtered with fastq_quality_filter, a function within the fastx-toolkit (v0.0.14), with command line options -p 90 and -q 20 to keep reads with at least a 20 Phred score at a minimum of 90% of the bases. To eliminate possible PCR artifacts from library preparation, we used in-house scripts to keep at most 5 reads that had the same sequence, where those above that threshold were filtered out. As this was paired end sequencing, we used in-house scripts to re-synchronize the reads that were kept into proper, ordered pairs between "R1" and "R2" fastqs for alignment. Reads were then aligned to the sacCer3 genome using STAR (v2.5.2b), ([@R20]) and the following options:--outFilterMultimapNmax 1,--outFilterMismatchNmax 2,--chimSegmentMin 15,--chimJunctionOverhangMin 15,--outSAMtype BAM Unsorted,--outFilterType BySJout,--outFilterScoreMin 1, and--outFilterMultimapNmax 1. The sacCer3 RefSeq GTF file was given for the option--sjdbGTFfile. Samtools (v1.3.1) ([@R47]) was used to eliminate alignments that did not contain properly paired reads or were not primary alignments. Bigwigs were then made using genomeCov within bedtools (v2.26), ([@R64]) as well as tool bedGrapthToBigWig ([@R40]).

To identify genes that had low 5^′^ levels of Spt6 ChIP-seq signal in *spt6*~*S8*→*A8*~ relative to WT, we calculated the log~2~ ratio of average signal between the first and second half of each gene for both *spt6*~*S8*→*A8*~ and WT. The variance of this score was calculated across three replicates, and genes with variance \< 0.01 for either *spt6*~*S8*→*A8*~ or WT were removed to select genes with consistent signal across replicates. For the remaining genes, the difference of ratios between *spt6*~*S8*→*A8*~ and WT were calculated (i:e., *log*2(*avg*(*WT first half signal*)/*avg*(*WT second half signal*))−*log*2(*avg*(*S*8*A first half signal*)/*avg*(*S*8*A second half signal*))). Those with a score of 0.15 or greater were selected for down stream analyses.

Once these genes were selected, Deeptools (v2.5.4) ([@R65]) tool computeMatrix in scale-region mode was used to make metagene plots about these genes for both H3 and Spt6 ChIP-seqs. Options included -b 200, -a 200, -bs 1, and -m 1000. As these ChIP-seq assays did not have spike-in corrections, all samples were plotted on a relative scale, where the minimum of the sample was set to 0, the max set to 1, and all other values scaled to fit this range. In plots where replicates were combined, replicates were first scaled (between 0 and 1) before taking and plotting the average of said replicates.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S25}
---------------------------------------

All the error bars in the ChIP qPCR experiments represent the mean ± standard deviation standard deviations from three biological replicates with three technical replicates in each experiment. Significance values were calculated using Student's t test. The Salmon (v0.8.1), function quant was used to quantify RNA counts over each gene, and DESeq2 (v1.14.1), was used to calculate differential genes (adjusted p value ≤ 0.05). All the ChIP-seq assays did not have spike-in corrections, all samples were plotted on a relative scale, where the minimum of the sample was set to 0, the max set to 1, and all other values scaled to fit this range. In plots where replicates were combined, replicates were first scaled (between 0 and 1) before taking and plotting the average of said replicates. Wilcoxon rank sum test was used to calculate the differences in the antisense transcript signals between the WT and the *spt6* mutants. \* represents p \< 0.05, \*\* represents p \< 0.01 and \*\*\* represents p \< 0.001.

DATA AND SOFTWARE AVAILABILITY {#S26}
------------------------------

The accession number for the RNaseq and ChIPseq data reported in this paper is GEO: GSE122620. Raw data for immunoblots can be found at <https://data.mendeley.com/datasets/zzc659t39m/draft?a=50b72eec-60d5-4b24-ba6c-e1e0938f4fd4>.
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![CKII Phosphorylation of the N Terminus of Spt6 Is Essential for Spt6 Function\
(A) Schematic representation of the Spt6 domain organization. Eight consensus CKII phosphorylation sites are indicated in a magnified version of the Spt6 N terminus.\
(B) Schematic representation of the SILAC experimental approach.\
(C) Differential abundance analysis of Spt6 peptides identified by SILAC and MS1 quantitation (n = 1). Peptides containing CKII consensus sites are indicated by the colors defined in the key. \*Abundance ratios were adjusted to an artificial minimum value due to detection in WT only; \*\*abundance ratios were adjusted to a maximum value due to detection in *ck2*^*ts*^ only.\
(D) *In vitro* CKII kinase assay using bacterially expressed, N-terminal 6X HIS-tagged Spt6 fragments (1--300, WT, and *spt6*~*S8→A8*~ mutant). Shown are the Coomassie staining (extreme left), anti-6X-HIS immunoblotting (middle), and γ^32^P-ATP radioactivity incorporation using the recombinant, commercially purified CKII enzyme (500 U/reaction) (right). Data shown are representative images of three biological replicates.\
(E) Left: a silver-stained SDS-PAGE gel of load levels for FLAG-Spt6 affinity purified from yeast, both FL WT and FL *spt6*~*S8*→*A8*~ mutant before kinase, and ^32^P-ATPγ addition. Right: an autoradiograph of *in vitro* CKII kinase assay using the same affinity-purified FLAG-Spt6. CKII autophosphorylation is also indicated.\
(F) Immunoblots using anti-FLAG antibody to detect FLAG-Spt6 from WT and *spt6*~*S8*→*A8*~ mutant cells after treatment with 100 mg/mL cycloheximide to inhibit protein translation. Cell lysates were prepared as described in Method Details. Glucose-6-phosphate dehydrogenase (G6PDH) was used as a loading control. Immunoblot experiments are representative images from three biological replicates. Values beneath the lanes represent the relative changes in Spt6 protein levels compared to G6PDH (error shown is the SD). The 0 time points in the WT and the *spt6*~*S8*→*A8*~ mutants were normalized to 100% or 1.\
(G) Spotting assay showing the growth and sensitivity of *spt6* and *ck2*^*ts*^ mutants at 37°C and under conditions of genotoxic stress (200 mM hydroxyurea \[HU\]).\
(H) Growth and sensitivity of the putative CKII phospho mutants *spt6*~*S8*→*A8*~ and phospho-mimic *spt6*~*S8*→*E8*~ as assessed in (G). For (G) and (H), the yeast spotting assays were repeated three times with three individual colonies, and the images shown are representative of the data.\
(I) Immunoblot analysis of the changes in the levels of Spt6, Set2, and H3K36me3 in asynchronously growing cultures of control (WT untagged Spt6 and WT FLAG-Spt6) and *spt6* mutants (*spt6*~*S8*→*A8*~ and *spt6*~*S8*→*E8*~) at 30°C and 37°C. H3 and G6PDH levels were used as loading controls. Immunoblot experiments were repeated three times, and the images shown are representative examples from three biological replicates.](nihms-1517610-f0001){#F1}

![CKII-Dependent Phosphorylation of Spt6 Maintains Nucleosome Occupancy at the 5^′^ Ends of Genes\
(A) Heatmap representing H3 ChIP-seq signal in WT, *spt6*~*S8*→*A8*~, and *spt6*~*S8*→*E8*~ cells for all genes ranked by RNA abundance in WT cells; 0% and 100% correspond to 5^′^ to 3^′^ open reading frame (ORF) ends. Plot extended ± 200 bp.\
(B) Metagene plot for H3 signal of all ORFs; 0% and 100% correspond to 5^′^ to 3^′^ ORF ends. Plot extended ± 200 bp.\
(C) Heatmap depicting Spt6 ChIP-seq signal in WT, *spt6*~*S8*→*A8*~, and *spt6*~*S8*→*E8*~ cells for all genes ordered by RNA abundance in WT cells; 0% and 100% correspond to 5^′^ to 3^′^ ORF ends. Plot extended ± 200 bp.\
(D) Metagene plot for Spt6 ChIP-seq signal in WT, *spt6*~*S8*→*A8*~, and *spt6*~*S8*→*E8*~ cells.](nihms-1517610-f0002){#F2}

![Spt6 Phosphorylation by CKII Is Required to Prevent Antisense Transcription\
(A) Antisense RNA-seq expression (TPM) associated with each gene was plotted for the *spt6* mutants relative to WT.\
(B) Venn diagram showing the similarity of antisense transcription in WT, *spt6--1004*, *spt6*~*S8*→*A8*~, and *spt6*~*S8*→*E8*~ mutants. The numbers in the circles represent the unique predicted antisense transcripts in the respective mutants.\
(C) Heatmap of antisense RNA-seq signal (black). A total of 971 differential antisense transcripts were predicted between WT and *spt6--1004*, coinciding with 829 genes. *spt6--1004* antisense RNA-seq signal (log~2~) was plotted across the 829 genes. The subplot at top right highlights 40 genes coinciding with differential antisense transcripts predicted between WT and *spt6*~*S8*→*A8*~. Yellow, outside of gene body; white-black, log~2~ antisense signal.\
(D) Antisense levels of the highlighted 40 genes between the 5^′^ and 3^′^ halves were compared. The 5^′^ half of the genes had significantly more antisense signal than the 3^′^ half (p \< 0.0001, Wilcoxon rank-sum).\
(E) On a per-gene basis, the 5^′^ and 3^′^ half ratios (log~2~) were plotted. While not every gene had higher 5^′^ signal relative to the 3′ half of the genes (8), 80% (or 32 genes) did.\
(F) Antisense levels of all 829 genes were compared between the 5^′^ and 3^′^ halves of the genes. Like the 40 highlighted genes, the 5^′^ halves had significantly more antisense signal relative to the 3^′^ halves (p \< 0.0001, Wilcoxon rank-sum).\
(G) The 5^′^ and 3^′^ half ratios were calculated for each of the 829 genes and plotted. Of the genes, 80.6% (668) had a higher signal in the 5^′^ half of the gene, while19.4% (161) had a higher antisense signal in the 3^′^ half of the gene.(H and I) Representative RNA-seq tracks of (H) *SMY1* and (I) *YTA6* genes.](nihms-1517610-f0003){#F3}

![CKII Phosphorylation of Spt6 Regulates Chromatin Integrity during Transcription\
(A) Schematic of the *SRG1* and *SER3* loci showing their expression patterns in WT and mutant strains, as indicated by red (WT) and green (mutant) arrows.\
(B) Representative RNA-seq tracks showing an increase in the expression level of the *SER3* gene in WT, *spt6*~*S8*→*A8*~, *spt6*~*S8*→*E8*~, and *spt6--1004* allele.\
(C) Quantitative real-time PCR detection of *SRG1* and *SER3* transcripts in the WT and *spt6--1004* mutant strain.\
(D) Quantitative real-time PCR detection of *SRG1* and *SER3* transcripts in the WT and *spt6* mutant (*spt6*~*S8*→*A8*~ and *spt6*~*S8*→*E8*~) strains.\
(E) ChIP analysis of histone H3 levels across *SRG1* and *SER3* was performed with WT and *spt6* mutant (*spt6*~*S8*→*A8*~ and *spt6*~*S8*→*E8*~) strains. Amplicons are indicated below the schematic diagram of the genes. Quantitative real-time PCR and ChIP data are represented as means ± SDs of three independent biological experiments. Asterisks indicate significance values (\*\*p \< 0.01); non-significant comparisons are not shown.\
All qPCR primer sequences (C and D) are listed in [Table S4](#SD5){ref-type="supplementary-material"}.](nihms-1517610-f0004){#F4}

![Spt6-Spn1 Interaction Is Dependent on CKII Phosphorylation of Spt6\
FLAG-tagged Spt6 was affinity purified from WT and *spt6*~*S8*→*A8*~ mutant cells using FLAG-M2 agarose beads, and the protein was subjected to MS analyses.\
(A) Correlation plot analysis of the bait normalized fold change values \* 100 for FLAG Spt6 isolated from the WT and *spt6*~*S8*→*A8*~ mutant. The red diamond indicates Spn1.\
(B) Relative levels of indicated proteins in the *spt6*~*S8*→*A8*~ mutant compared with WT.\
(C) Co-immunoprecipitation (coIP) showing the interaction of Spt6 and Spn1. Spn1 was immunoprecipitated by anti-V5 antibody, and Spt6 was detected using anti-FLAG antibody. Set2 protein was used as a control. These experiments were performed three times, and a representative example of this same experiment is shown in [Figure S5B](#SD1){ref-type="supplementary-material"}.\
(D) Interaction of Spt6 and Spn1 is phospho-dependent. Lysates were prepared from WT cells expressing FLAG-Spt6 and V5-tagged Spn1. Spn1 was immobilized on protein G agarose beads, and the complex was treated with lambda phosphatase. Immunoblots were performed for Spt6 and Spn1 after two washes. Co-IPs were performed three times and the immunoblots shown are representative images of these experiments; an additional example in which this experiment was performed reciprocally (i.e., immunoprecipitation of Spt6 before lambda phosphatase treatment) is shown in [Figure S5C](#SD1){ref-type="supplementary-material"}.\
(E) Spotting assay showing the growth and sensitivity of single mutants of *spt6 and spn1* (top) and double mutants of *spn1* mutant (*spn1-R263D*) and *spt6*~*S8*→*A8*~ at 37°C and under conditions of genotoxic stress 200 mM hydroxyurea (HU). All of the spotting assays were performed three independent times with independent colonies; shown are representative images.\
(F) Immunoblots showing the changes in the levels of H3K36me3, H3K36me3, Spt6, and RNAPII in the single and double mutants of *spn1-R263D* and *spt6*~*S8*→*A8*~. All of the immunoblots were performed three independent times using independent clones.](nihms-1517610-f0005){#F5}

![A Model for CKII-Mediated Control of Spt6 Function during Transcription\
During transcription, CKII phosphorylates Spt6 within its N terminus, promoting Spn1 association and proper nucleosome reassembly, which prevents inappropriate transcription from within gene bodies. If Spt6 is not phosphorylated, Spn1 interaction is reduced, causing defects in Spt6 and RNAPII localization, and nucleosome deposition defects that permit cryptic sense and antisense transcription.](nihms-1517610-f0006){#F6}

###### KEY RESOURCES TABLE

  REAGENT or RESOURCE                                              SOURCE                            IDENTIFIER
  ---------------------------------------------------------------- --------------------------------- -------------------------------------------------------------------------------------------------------
  Antibodies                                                                                         
  Anti-V5 antibody. Polyclonal                                     Bethyl labs                       Catalog \#A190--220A
  Anti RNAPII Ser2 monoclonal, (Clone 9E10)                        Active Motif                      Catalog \#61084
  Anti-Spt6, polyclonal                                            In House                          N/A
  Anti-histone H3 C-terminal antibody, polyclonal                  EpiCypher                         Catalog \# 13--0001
  Anti-Histone H3K36me3                                            Abcam                             ab9050
  Anti-Histone H3K79me3                                            Abcam                             Ab2621
  Anti-Histone H3K4me3                                             Active Motif                      39159
  Anti-FLAG M2 mouse monoclonal antibody                           Sigma Aldrich                     F1804
  Anti Set2                                                        In House                          N/A
  Normal rabbit serum                                              Cell Signaling Technology         Catalog \# 2729S
  Anti-G6PDH antibody, polyclonal                                  Sigma                             Catalog \# A9521--1VL
  ChIP grade RNAPII antibody                                       BioLegend                         Catalog \# 664912
  HRP-conjugated anti-rabbit                                       GE Healthcare                     Catalog \# NA934V
  HRP-conjugated anti-mouse                                        GE Healthcare                     Catalog \# NA931V
  Normal Rabbit IgG                                                Cell Signaling Technology         27295
  Chemicals, Peptides, and Recombinant Proteins                                                      
  6-Azauracil                                                      SIGMA (Roche)                     Catalog \# A1757
  Hydroxyurea                                                      SIGMA (Roche)                     Catalog \# H8627
  SSIII RT reverse transcriptase                                   Thermo Fisher Scientific          Catalog \# 18080--044
  Acid phenol Chloroform                                           Ambion/Thermo Fisher Scientific   Catalog \# AM9722
  cOMPLETE, EDTAfree protease inhibitor tablets                    SIGMA (Roche)                     Catalog \# 11873580001
  PhosSTOP phosphatase inhibitor tablets                           SIGMA (Roche)                     Catalog \# 04906845001
  iTaq Universal SYBR ® Green Supermix                             Biorad                            Catalog \# 172--5124
  Protein A Agarose                                                SIGMA (Roche)                     Catalog \# 11134515001
  FLAG_M2 Agarose beads                                            Sigma Aldrich                     A2220
  Dynabeads Protein G                                              Thermo Fisher Scientific          Catalog \# 10009D
  SPRI Beads (Agencourt AMPure XP)                                 Beckman Coulter                   Catalog \# A63881
  Flexible Fused Silica Capillary Tubing, Inner Diameter 100μm     Polymicro Technologies            \#1068150023
  Reversed phase resin Aqua 5U C18 125A                            Phenomenex                        \#04A-4299
  Strong cation exchange resin Luna 5um SCX 100A                   Phenomenex                        \#04A-4398
  Arginine/Lysine Dropout mix                                      Sunrise science products          \#1198--100
  SILAC heavy arginine                                             Cambridge Isotope Laboratories    NLM-396-PK
  SILAC heavy lysine                                               Cambridge Isotope Laboratories    DLM-2640-PK
  Light arginine                                                   Fisher                            BP 370--100
  Light lysine                                                     Fisher                            BP 386--100
  Yeast nitrogen base without amino acids                          Becton, Dickinson, and company    \#291940
  IPTG                                                             RPI Biosciences                   156000--100.0
  Recombinant Casein Kinase II                                     New England Biolabs               P6010S
  ATP, \[γ-32P\]-6000Ci/mmol, 10mCi/ml,                            Perkin Elmer                      BLU002Z500UC
  Cycloheximide                                                    Sigma Aldrich                     C 4859--1ML
  Lysozyme                                                         Sigma                             L6876
  Universal Nuclease                                               Pierce                            88700
  Spt6-WT (aa1--300)                                               This Study                        N/A
  Spt6~8S→8A~ (aa1--300)                                           This study                        N/A
  Spn1(aa 141--405)                                                This study                        N/A
  Critical Commercial Assays                                                                         
  TruSeq Stranded Total RNA with RiboZero Gold Library Prep Kit.   Illumina                          Catalog \# RS-122--2301
  End Repair and A Tailing Buffer                                  KAPA Hyper Prep Kit               KK8502
  KAPA Pure beads                                                  KAPA Hyper Prep Kit               KK8002
  SeqCap Adaptor Kit B                                             Roche                             07 141 548 001
  SeqCap Adaptor Kit A                                             Roche                             07 141 530 001
  Deposited Data                                                                                     
  RNaseq and ChIPSeq seq data                                      This study                        GEO:GSE122620
  Raw data for Immunoblots                                         This Study                        Mendeley:<https://data.mendeley.com/datasets/zzc659t39m/draft?a=50b72eec-60d5-4b24-ba6c-e1e0938f4fd4>
  Data analysis software                                                                             
  Proteome Discoverer 2.2 Sequest                                  ThermoFisher                      OPTON-30795
  Experimental Models: *S. cerevisiae* strains                                                       
  *S.cerevisiae yeast strains*                                     This study and other sources      [Table S2](#SD3){ref-type="supplementary-material"}
  Oligonucleotides                                                                                   
  Oligos                                                           This study and other sources      [Table S4](#SD5){ref-type="supplementary-material"}
  Recombinant DNA                                                                                    
  Plasmids generated during this study                             This study                        [Table S3](#SD4){ref-type="supplementary-material"}

###### Highlights

-   Casein kinase II (CKII) phosphorylates the unstructured N terminus of Spt6

-   CKII phosphorylation of Spt6 prevents sense and antisense transcription

-   In Spt6 mutants, antisense transcripts arise from the 5′ ends of genes

-   CKII phosphorylation of Spt6 promotes Spt6-Spn1 interaction
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